These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15067161)

  • 21. Ambiguity in determining financial capability of SSI and SSDI beneficiaries with psychiatric disabilities.
    Lazar CM; Black AC; McMahon TJ; O'Shea K; Rosen MI
    Psychiatr Serv; 2015 Mar; 66(3):279-84. PubMed ID: 25727116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use and assignment of representative payees.
    Rosen MI; Rosenheck R
    Psychiatr Serv; 1999 Jan; 50(1):95-8. PubMed ID: 9890587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A proposal for future funding of chronic and episodic mental illness. 1986.
    Talbott JA; Sharfstein SS
    Psychiatr Serv; 2004 Oct; 55(10):1145-9. PubMed ID: 15492082
    [No Abstract]   [Full Text] [Related]  

  • 24. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing dual diagnosis services for clients with severe mental illness.
    Drake RE; Essock SM; Shaner A; Carey KB; Minkoff K; Kola L; Lynde D; Osher FC; Clark RE; Rickards L
    Psychiatr Serv; 2001 Apr; 52(4):469-76. PubMed ID: 11274491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The quiet epidemic.
    Ryan P
    Calif Hosp; 1993; 7(1):8-11. PubMed ID: 10171358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive Case Management for Addiction to promote engagement with care of people with severe mental and substance use disorders: an observational study.
    Morandi S; Silva B; Golay P; Bonsack C
    Subst Abuse Treat Prev Policy; 2017 May; 12(1):26. PubMed ID: 28545572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing standards of care for individuals with co-occurring psychiatric and substance use disorders.
    Minkoff K
    Psychiatr Serv; 2001 May; 52(5):597-9. PubMed ID: 11331791
    [No Abstract]   [Full Text] [Related]  

  • 30. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
    Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SSDI recipients can earn more money.
    WORLD; 1999 Oct; (No 102):7. PubMed ID: 11366919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the cost impact of three dual diagnosis treatment programs.
    Jerrell JM; Hu TW
    Eval Rev; 1996 Apr; 20(2):160-80. PubMed ID: 10182202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual diagnosis of severe mental illness and substance misuse: a case for specialist services?
    Johnson S
    Br J Psychiatry; 1997 Sep; 171():205-8. PubMed ID: 9337968
    [No Abstract]   [Full Text] [Related]  

  • 34. Behavioral health issue brief: mental health and substance abuse parity: year end report-2002.
    Delaney T; Crean E
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-16. PubMed ID: 12875267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Income and employment of people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Conover CJ; Arno P; Weaver M; Ang A; Ettner SL
    J Ment Health Policy Econ; 2006 Jun; 9(2):71-86. PubMed ID: 17007485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral health issue brief: minimum mandated benefits and mandated offerings for mental health and substance abuse: year end report-2002.
    Delaney T; Crean E
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-24. PubMed ID: 12875270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case managers' and clients' perspectives on a representative payee program.
    Dixon L; Turner J; Krauss N; Scott J; McNary S
    Psychiatr Serv; 1999 Jun; 50(6):781-6. PubMed ID: 10375147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial Capability: Clinicians' Assessment of Beneficiaries With Dual Diagnoses.
    Thornhill Iv TA; Black AC; Rosen MI
    J Dual Diagn; 2018; 14(2):130-136. PubMed ID: 29505348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Client predictors of employment outcomes in high-fidelity supported employment: a regression analysis.
    Campbell K; Bond GR; Drake RE; McHugo GJ; Xie H
    J Nerv Ment Dis; 2010 Aug; 198(8):556-63. PubMed ID: 20699720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic grand rounds: the costs of parity mandates for mental health and substance abuse insurance benefits.
    Sing M; Hill SC
    Psychiatr Serv; 2001 Apr; 52(4):437-40. PubMed ID: 11274485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.